Skip to main content Accessibility help
×
Home
Hostname: page-component-768dbb666b-bxbhv Total loading time: 0.829 Render date: 2023-02-07T14:12:56.689Z Has data issue: true Feature Flags: { "useRatesEcommerce": false } hasContentIssue true

Case 35 - You Have Been Diagnosed with Alzheimer Disease; Is That It?

from Part 7 - Misinterpreting Test Results

Published online by Cambridge University Press:  03 November 2020

Keith Josephs
Affiliation:
Mayo Clinic Alzheimer’s Disease Research Center
Federico Rodriguez-Porcel
Affiliation:
Medical University of South Carolina
Rhonna Shatz
Affiliation:
University of Cincinnati
Daniel Weintraub
Affiliation:
University of Pennsylvania
Alberto Espay
Affiliation:
University of Cincinnati
Get access

Summary

This 51-year-old right-handed woman requested further care for her previously diagnosed Alzheimer disease. Over the previous year, her coworkers observed that she would frequently forget instructions and conversations and increasingly relied on written reminders. She would ask the same question repeatedly and cueing helped inconsistently. Her symptoms had not worsened since. There were no language or visuospatial impairments. Her past medical history included lumpectomy and tamoxifen for breast cancer five years ago, and a 30-year history of alcohol abuse (daily beer and vodka, unknown volume). Indeed, family members reported finding empty bottles of vodka in the garbage. She had no family history of cognitive impairment or other neurologic condition. Previous work up included a normal blood work, brain MRI with contrast, normal cell count, protein, glucose, and cytology in cerebrospinal fluid, but bilateral temporoparietal hypometabolism on FDG-PET (Figure 35.1). With a presumed diagnosis of Alzheimer disease, she was started on donepezil 5 mg daily.

Type
Chapter
Information
Common Pitfalls in Cognitive and Behavioral Neurology
A Case-Based Approach
, pp. 110 - 112
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bateman, R. J. et al. 2012. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med 367(9) 795804.
Berti, V., Mosconi, L. and Pupi, A. 2014. Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. PET Clin 9(2) 129140.
Bohnen, N. I. et al. 2012. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med 53(1) 5971.
Buckner, R. L. et al. 2005. Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25(34) 77097717.
Daulatzai, M. A. 2017. Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s disease. J Neurosci Res 95(4) 943972.
Dubois, B. et al. 2016. Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement 12(3) 292323.
Engler, H. et al. 2006. Two-year follow-up of amyloid deposition in patients with Alzheimer’s disease. Brain 129(Pt 11) 28562866.
Foster, N. L. et al. 2007. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Brain 130(Pt 10) 26162635.
Furst, A. J. et al. 2012. Cognition, glucose metabolism and amyloid burden in Alzheimer’s disease. Neurobiol Aging 33(2) 215225.
Jagust, W. et al. 2007. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology 69(9) 871877.
Johnson, K. A., Fox, N. C., Sperling, R. A. and Klunk, W. E. 2012. Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med 2(4) a006213.
Landau, S. M. et al. 2010. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75(3) 230238.
Mosconi, L. et al. 2008. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med 49(3) 390398.
Perani, D. et al. 2014. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. Neuroimage Clin 6 445454.
Raichle, M. E. 2015. The brain’s default mode network. Annu Rev Neurosci 38 433447.
Roberts, R. O. et al. 2014. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J Nucl Med 55(5) 759764.
Rocher, A. B. et al. 2003. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage 20(3) 18941898.
Villemagne, V. L. et al. 2013. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol 12(4) 357367.

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×